News
- Author:
- Jim Kling
Publish date: January 25, 2024
The test has excellent prognostic value for colorectal cancer, but clinicians aren’t ready to commit to using it to deescalate adjuvant therapy.
News
- Author:
- Jim Kling
Publish date: January 23, 2024
The results of a new trial may point the way to other dual therapies involving kinase inhibitors, says expert.
News
- Author:
- Jim Kling
Publish date: December 12, 2023
A new study shows that a lower dose of tamoxifen leads to better adherence, and another shows similar efficacy at reducing breast density.
News
- Author:
- Jim Kling
Publish date: December 12, 2023
Drug’s novel mechanism of action raises hopes of disease-modifying activity, but long-term cost-effectiveness rests on improvement in functional st...
News
- Author:
- Jim Kling
Publish date: December 11, 2023
Taxane exposure during pregnancy appears to be safe for mothers and offspring.
News
- Author:
- Jim Kling
Publish date: December 11, 2023
For women who were cancer free 3 years after curative treatment, a randomized trial showed noninferiority of a 2- or 3-year schedule compared with ...
News
- Author:
- Jim Kling
Publish date: December 8, 2023
The antibody-drug conjugate demonstrated greater efficacy and a better safety profile than investigator-chosen chemotherapy.
News
- Author:
- Jim Kling
Publish date: December 7, 2023
Brain metastases are common in HER2+ breast cancers, but patients have few treatment options and a poor prognosis.
News
- Author:
- Jim Kling
Publish date: November 21, 2023
Minimal disease manifestation is meaningful for patients, but should be weighed against potential side effects.
News
- Author:
- Jim Kling
Publish date: November 14, 2023
Programs can generate health care and research content, but require close supervision and an attitude of ‘trust, but verify.’
News
- Author:
- Jim Kling
Publish date: November 8, 2023
A study of the NIH All of Us database shows a higher prevalence of myasthenia gravis than what has been reported in previous studies.
News
- Author:
- Jim Kling
Publish date: November 8, 2023
Long waits for neuropsychiatric evaluations make it difficult to get help, but an NIH tool may help.
News
- Author:
- Jim Kling
Publish date: November 6, 2023
Advancements are set to alter the approach to some patients and inspire a demand for genetic counselors in neuromuscular clinics.
News
- Author:
- Jim Kling
Publish date: November 3, 2023
New class of therapies interfere with IgG recycling and have similar efficacy across multiple cycles of treatment.
News
- Author:
- Jim Kling
Publish date: October 30, 2023
Broad-acting biologic reduced exacerbations and use of maintenance steroids in patients that tend to be sicker.
